PP
ARNA

PDT Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

PDT Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-20,510
Closed -$392K – 1062
2015
Q3 		$392K Buy
20,510
+6,800
+50% +$231K 0.01% 976
2015
Q2 		$636K Sell
13,710
-2,940
-18% -$128K 0.02% 898
2015
Q1 		$728K Buy
16,650
+5,310
+47% +$247K 0.02% 890
2014
Q4 		$393K Hold
11,340
– – 0.04% 487
2014
Q3 		$475K Buy
11,340
+4,590
+68% +$205K 0.01% 957
2014
Q2 		$396K Sell
6,750
-6,080
-47% -$383K 0.01% 1102
2014
Q1 		$808K Buy
+12,830
New +$851K 0.02% 757

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PDT Partners's ARNA Position: Q4 2015 in Review

PDT Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2015, closing a stake of 20,510 shares — an estimated $392K sold.

PDT Partners first reported a position in ARNA in Q1 2014 and held it in 7 quarters. The position peaked at $808K in Q1 2014. 121 funds tracked by Wall St. Rank hold ARNA as of Q4 2015.

  • PDT Partners reported no remaining Arena Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • PDT Partners sold 20,510 Arena Pharmaceuticals Inc shares in Q4 2015, an estimated $392K.
  • PDT Partners first reported a position in Arena Pharmaceuticals Inc in Q1 2014 and held it in 7 quarters.
  • PDT Partners's Arena Pharmaceuticals Inc position peaked at $808K in Q1 2014.
  • 121 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2015.

Based on PDT Partners's 13F filing for Q4 2015, filed 16 Feb 2016.